Chung, Hak Suk Principal Researcher
– Ph.D. Harvard University, Chemical Biology (2007)
– M.A. Princeton University, Organic Chemistry (2003)
– M.S. Korea University, Organic Chemistry (1998)
– B.S. Sookmyung Women’s University, Chemistry (1996)
– Seniore Researcher, Korea Institute of Science & Technology (KIST) (2012~)
– Assistant, Associate Professor, University of Science and Technology (2012~)
– Post-Doc, Duke Medical Center, Durham, NC(2007-2012)
– Develop Adjuvant plaform for cancer, allergy, and Alzheimer immunotherapy
– Understand molecular mechanisms of enzymes and proteins involved in diverse cellular processes and disease utilizing protein structures
– Selected publications
The same as above
– Selected patents
- Bacteria producing hexa-acylated monophosphoryl lipid A, and method for the production of hexa-acylated monophosphoryl lipid A using the same. 2017 (Korea, granted), Filing at 2017 or 2018 (PCT, Russia, Europe, USA, Japan, China, India, Canada, Australia)
- Bacteria constitutively producing monophosphoryl lipid A, and method for the production of monophosphoryl lipid A using the same Filing at 2017 or 2018 (Korea, USA, PCT)
- Method for producing monomeric CARD in bacterial cell. Filing at 2017 (Korea)
4. Bacteria producing monophosphoryl lipid A, and method for the production of monophosphoryl lipid A using the same. (Korea, granted at 2017)
- Composition for dephosphorylating lipid and method for the production of dephosphorylated lipid using the same. (Korea, granted at 2017)
– Technique transfer
Techniques “Direct technique producing adjuvant, monophosphoryl lipid A” was transferred to Eubiologics (Downpayment: ~ $ 270,000, milestone payments: $ 6 million, loyalty: 2-5% of net sales)